Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases

References

• Fujii T, Akizuki M, Kameda H, Matsumura M, Hirakata M, Yoshida T, et al. Methotrexate treatment in patients with adult onset Still's disease—retrospective study of 13 Japanese cases. Ann Rheum Dis. 1997;56(2):144–8.
   PubMed Web of Science ®Google Scholar
• Omagari K, Matsunaga Y, Yamashita H, Nishiyama H, Hazama H, Oda H, et al. Cyclosporine A in the treatment of adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia. Am J Med Sci. 2003;326(3):148–51.
   PubMed Web of Science ®Google Scholar
• Fautrel B, Sibilia J, Mariette X, Combe B; Club Rheumatisms et Inflammation. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis. 2005;64(2):262–6.
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheum. 2002;46(12):3388–9.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19(3):424–30.
   PubMed Web of Science ®Google Scholar
• Murakami K, Fujii T, Yukawa N, Yoshifuji H, Kawabata D, Tanaka M, et al. Successful treatment of a patient with refractory adult Still's disease by tacrolimus. Mod Rheumatol. 2007;17(2):167–70.
   PubMedGoogle Scholar
• Mitamura M, Tada Y, Koarada S, Inoue H, Suematsu R, Ohta A, Nagasawa K. Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease. Mod Rheumatol. 2009;19(1): 57–63.
   PubMed Web of Science ®Google Scholar
• Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis. 2004;63(10):1300–6.
   PubMed Web of Science ®Google Scholar
• Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum. 2001;44(3):550–60.
   PubMed Web of Science ®Google Scholar
• Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem. 2000;7(7):731–48.
   PubMed Web of Science ®Google Scholar
• Kuninose M, Iwagaki H, Morimoto Y, Kohka H, Kobashi K, Sadamori H, et al. Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions. Acta Med Okayama. 2000;54(5):201–9.
   PubMed Web of Science ®Google Scholar
• Park JH, Bae JH, Choi YS, Jun JB, Jung S, Yoo DH, et al. Adult onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A. J Korean Med Sci. 2004;19(1):137–41.
   PubMed Web of Science ®Google Scholar
• Kam S, Andrew C, Karen R. Cyclosporin A in the treatment of adult Still's disease. J Rheumatol. 1995;22(7):1391–2.
   PubMed Web of Science ®Google Scholar
• List AF, Kopecky KJ, Willman CL, Heas DR, Slovak ML, Douer D, et al. Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase. Blood. 2002;100(5):1910–2.
   PubMed Web of Science ®Google Scholar
• Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med. 2006;38(1):20–31.
   PubMed Web of Science ®Google Scholar
• Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89(11):4100–3.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Hirase N, Goda H, Nishikawa H, Ikuyama S. Oral low-dose tacrolimus therapy for refractory hemophagocytic syndrome associated with systemic lupus erythematosus. Mod Rheumatol. 2012;22(2):284–9.
   PubMed Web of Science ®Google Scholar
• Kainz A, Harabacz I, Cowrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation. 2000;70(12):1718–21.
   PubMed Web of Science ®Google Scholar
• Alsuwaida A. Successful management of systemic lupus erythematosus nephritis flare-up during pregnancy with tacrolimus. Mod Rheumatol. 2011;21(1):73–5.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Tabeya T, Suzuki C, Naishiro Y, Yajima H, Shimizu Y, et al. Adult-onset Still's disease in pregnancy. Mod Rheumatol. 2012;22(1):163–5.
   PubMed Web of Science ®Google Scholar
• Pan VL, Haruyama AZ, Guberman C, Kitridou RC, Wing DA. Newly diagnosed adult-onset Still disease in pregnancy. Obstet Gynecol. 2003;101(5 Pt 2):1112–6.
   PubMed Web of Science ®Google Scholar
• Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest. 1993;91(5):2144–9.
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Kawai S, Yamamoto K, Harigai M, Ishida K, Miyasaka N. Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2014;24(1):8–16.
   PubMed Web of Science ®Google Scholar
• Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis. 2006;65(5):564–72.
   PubMed Web of Science ®Google Scholar
• Kotter I, Wacker A, Koch S, Henes J, Richter C, Engel A, et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum. 2007;37(3):189–97.
   PubMed Web of Science ®Google Scholar